Home » Topics » Regulatory

Regulatory
RSS

FDA approves new indications for Zerit and Videx

Sep. 9, 1999

New ulcer drug approved for the first time in Japan

Sep. 1, 1999

Eisai's proton pump inhibitor approved in E.U. for GERD maintenance

Sep. 1, 1999

Celecoxib NDA receives priority review designation for FAP

Aug. 31, 1999

NDA for subcutaneous Repronex approved by FDA

Aug. 31, 1999

Temodal approved in E.U. for treatment of recurrent anaplastic astrocytoma

Aug. 27, 1999

InterMune files BLA for Actimmune for treatment of osteopetrosis

Aug. 25, 1999

Bio-Technology General granted additional patent allowance for oxandrolone

Aug. 24, 1999

QLT begins phase II trial for psoriasis treatment

Aug. 24, 1999

Chiron initiates phase III study of Proleukin for HIV

Aug. 23, 1999

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...